SUSQUEHANNA INTERNATIONAL GROUP, LLP - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 205 filers reported holding NPS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$46,808,000
+26.8%
1,308,566
-7.9%
0.02%
+28.6%
Q3 2014$36,927,000
-25.7%
1,420,215
-5.6%
0.01%
-33.3%
Q2 2014$49,733,000
+90.1%
1,504,797
+72.2%
0.02%
+75.0%
Q1 2014$26,155,000
-15.9%
873,863
-14.7%
0.01%
-20.0%
Q4 2013$31,095,000
-2.1%
1,024,204
+2.6%
0.02%
-6.2%
Q3 2013$31,756,000
+238.6%
998,339
+60.7%
0.02%
+220.0%
Q2 2013$9,380,000621,2380.01%
Other shareholders

There were no reported owners of NPS PHARMACEUTICALS INC in Q3 2014.

NameSharesValueWeighting ↓
View complete list of NPS PHARMACEUTICALS INC shareholders